Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1956 1
1959 1
1964 2
1965 3
1967 2
1968 1
1969 1
1970 2
1971 1
1974 2
1975 2
1976 2
1978 1
1979 4
1980 3
1981 3
1982 1
1983 5
1984 13
1985 12
1986 8
1987 12
1988 7
1989 12
1990 16
1991 17
1992 13
1993 17
1994 19
1995 23
1996 23
1997 29
1998 34
1999 45
2000 45
2001 41
2002 67
2003 72
2004 107
2005 125
2006 142
2007 156
2008 165
2009 205
2010 249
2011 297
2012 319
2013 378
2014 432
2015 489
2016 514
2017 547
2018 618
2019 705
2020 814
2021 963
2022 675
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

7,562 results
Results by year
Filters applied: . Clear all
Page 1
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, Shen L, Shu Y, Wang C, Dai T, Mao T, Chen L, Guo Z, Liu B, Pan H, Cang S, Jiang Y, Wang J, Ye M, Chen Z, Jiang D, Lin Q, Ren W, Wang J, Wu L, Xu Y, Miao Z, Sun M, Xie C, Liu Y, Wang Q, Zhao L, Li Q, Huang C, Jiang K, Yang K, Li D, Liu Y, Zhu Z, Chen R, Jia L, Li W, Liao W, Liu HX, Ma D, Ma J, Qin Y, Shi Z, Wei Q, Xiao K, Zhang Y, Zhang Y, Chen X, Dai G, He J, Li J, Li G, Liu Y, Liu Z, Yuan X, Zhang J, Fu Z, He Y, Ju F, Liu Z, Tang P, Wang T, Wang W, Zhang J, Luo X, Tang X, May R, Feng H, Yao S, Keegan P, Xu RH, Wang F. Wang ZX, et al. Among authors: pan h. Cancer Cell. 2022 Mar 14;40(3):277-288.e3. doi: 10.1016/j.ccell.2022.02.007. Epub 2022 Mar 3. Cancer Cell. 2022. PMID: 35245446 Clinical Trial.
COMMD10 inhibits HIF1α/CP loop to enhance ferroptosis and radiosensitivity by disrupting Cu-Fe balance in hepatocellular carcinoma.
Yang M, Wu X, Hu J, Wang Y, Wang Y, Zhang L, Huang W, Wang X, Li N, Liao L, Chen M, Xiao N, Dai Y, Liang H, Huang W, Yuan L, Pan H, Li L, Chen L, Liu L, Liang L, Guan J. Yang M, et al. Among authors: pan h. J Hepatol. 2022 May;76(5):1138-1150. doi: 10.1016/j.jhep.2022.01.009. Epub 2022 Jan 29. J Hepatol. 2022. PMID: 35101526 Free article.
Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.
Liu X, Jin S, Hu S, Li R, Pan H, Liu Y, Lai P, Xu D, Sun J, Liu Z, Gao Y, Zhao Y, Liu F, Xiao Y, Li Y, Wen Y, Chen Z, Xu B, Lin Y, Ran M, Li Q, Yang S, Li H, Tu P, Haniffa M, Teichmann SA, Bai F, Wang Y. Liu X, et al. Among authors: pan h. Nat Commun. 2022 Mar 3;13(1):1158. doi: 10.1038/s41467-022-28799-3. Nat Commun. 2022. PMID: 35241665 Free PMC article.
Randomized Trial of First-Line Tyrosine Kinase Inhibitor With or Without Radiotherapy for Synchronous Oligometastatic EGFR-Mutated NSCLC.
Wang XS, Bai YF, Verma V, Yu RL, Tian W, Ao R, Deng Y, Xia JL, Zhu XQ, Liu H, Pan HX, Yang L, He YK, Bai HS, Luo X, Guo Y, Zhou MX, Sun YM, Zhang ZC, Li SM, Cheng X, Tan BX, Han LF, Liu YY, Zhang K, Zeng FX, Jia L, Hao XB, Wang YY, Feng G, Xie K, Lu Y, Zeng M. Wang XS, et al. Among authors: pan hx. J Natl Cancer Inst. 2022 Jan 30:djac015. doi: 10.1093/jnci/djac015. Online ahead of print. J Natl Cancer Inst. 2022. PMID: 35094066
7,562 results